USPTO 2015–2025 USPTO PatentsView US Corporation

Rhythmia Medical Inc.

USPTO PatentsView assignee record - 18 granted patents across 4 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Rhythmia ranks #16,316 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 4 technology areas.

#16,316
of 49,997 US assignees by volume
40th percentile
by Innovation Score (32.2/100)
26.7
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16316 · US Corporation #16,316 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 18 grants
  • MID-PACK #16,316/49,997
  • PHOTO-FINISH Rennovia
  • CPC-NARROW A61B · 4 areas
  • INNOV-THIN 32.2/100
  • CLAIMS-DENSE 26.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rennovia Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rhythmia’s 32.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Rhythmia

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Rhythmia's Innovation Score is 32.2/100 (40th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Rhythmia?

Each dot is one of Rhythmia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rhythmia’s own 26.7 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Rhythmia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 17.917.91818.1 010203040 Granted patents (volume) Avg claims / patent Rennovia Inc. - 18, 37.39RennoviaResearch Corporation Technologies, Inc. - 18, 16ResearchRheem Australia PTY Limited - 18, 15.44Rheem Australia P…Rheon Automatic Machinery Co., Ltd. - 18, 11.11Rheon Automatic M…Ripcord Inc. - 18, 17.39RipcordRoof Systems Germany GmbH - 18, 14.89Roof Systems Germ…RoundhouseOne Inc. - 18, 22RoundhouseoneS&S Tech Co., Ltd. - 18, 20.11S&S TechRhythmia Medical Inc. - 18, 26.67Rhythmia Medical
Rhythmia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rhythmia's grants concentrate

Rhythmia Medical Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (9 grants) versus a trough of 2 in 2019. By volume, Rhythmia sits between Rennovia Inc. and S&S Tech Co., Ltd..

Who files at Rhythmia's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Rhythmia holds 18 patents at rank #16,316, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Rhythmia

By rank, the assignees closest to #16,316 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Rhythmia's primary technology class.

Rhythmia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 40th percentile higher than 40% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 201520162019 2
USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Rhythmia Medical Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 9 50.0%
2016 7 38.9%
2019 2 11.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Rhythmia Medical Inc.'s patent record in context - here's where to go next.

  • Rhythmia Medical Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #16,316 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Rhythmia Medical Inc. against Rennovia Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 32.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.